DB05769InvestigationalSmall molecule
LCP-AtorFen is a fixed-dose combination therapy for the treatment of high cholesterol levels combining atorvastatin (the active ingredient of Lipitor®) and the lowest dose of fenofibrate without food effect. LCP-AtorFen... LCP-AtorFen is designed to be a once daily tablet offering a powerful and safe treatment of high cholesterol levels, addressing three primary cardiovascular risk factors: low density lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol (HDL-C)...
- Primary indication
- Investigated for use/treatment in hyperlipidemia.Curator reviewed
What you can answer from here — as of April 02, 2025
Which companies are running trials of LCP-AtorFen, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account